IXC 10.5% 6.0¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-147

  1. 15,516 Posts.
    lightbulb Created with Sketch. 1280
    yep but that’s the issue at the moment. There is no need to rush to buy in as nothing of substance is happening for a while.

    I feel people who are interested will by closer to results. For now no one wants to sit on a share where in 2 years it could have 20% capital growth
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.007(10.5%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $3.264K 54.4K

Buyers (Bids)

No. Vol. Price($)
1 600 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.